FDA Warning

FDA Warning

Etravirine, an antiretroviral, has been linked to several skin and hypersensitivity reactions.

Etravirine, (Intelence), a valuable antiretroviral drug has been associated with severe skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, and hypersensitivity reactions characterized by rash. Patients experiencing any of these signs or symptoms should discontinue use of the drug immediately according to the agency.

The FDA does not state how many people experience this complication. The box label had these same reations as very rare. This is exactly the type of meddling that the FDA is doing these days. Many companies are scared off this type of regulatory behavior. It is time for a change in the FDA.